Explaining observed infection and antibody age-profiles in populations with urogenital schistosomiasis.
Urogenital schistosomiasis is a tropical disease infecting more than 100 million people in sub-Saharan Africa. Individuals in endemic areas endure repeated infections with long-lived schistosome worms, and also encounter larval and egg stages of the life cycle. Protective immunity against infection...
Main Authors: | Kate M Mitchell, Francisca Mutapi, Nicholas J Savill, Mark E J Woolhouse |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-10-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC3197645?pdf=render |
Similar Items
-
Identifying and evaluating field indicators of urogenital schistosomiasis-related morbidity in preschool-aged children.
by: Welcome M Wami, et al.
Published: (2015-03-01) -
Comparative Assessment of Health Benefits of Praziquantel Treatment of Urogenital Schistosomiasis in Preschool and Primary School-Aged Children
by: Welcome M. Wami, et al.
Published: (2016-01-01) -
Immunomics-Guided Antigen Discovery for Praziquantel-Induced Vaccination in Urogenital Human Schistosomiasis
by: Mark S. Pearson, et al.
Published: (2021-05-01) -
Haematological Profile and Intensity of Urogenital Schistosomiasis in Ghanaian Children
by: Justice Afrifa, et al.
Published: (2017-01-01) -
Paediatric schistosomiasis: What we know and what we need to know.
by: Derick N M Osakunor, et al.
Published: (2018-02-01)